FIELD: medicine. SUBSTANCE: method involves determining proportion between active interferon quantity produced by blood cells as a result of their stimulation with cytokine and then treating the blood cells with the cytokine inductor and active interferon quantity produced by the blood cells as a result of their stimulation with the cytokine inductor only. EFFECT: high accuracy of the method. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING LIVING ORGANISM AND/OR ITS CELLS SENSITIVITY TO ACTING FIELD, SUBSTANCE OR COMBINATIONS OF FIELDS AND/OR SUBSTANCES | 2001 |
|
RU2202363C2 |
SUPPOSITORIES AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASES TRANSMITTED BY GENITAL TRACTS | 1999 |
|
RU2147873C1 |
METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
METHOD FOR TREATING THE CASES OF LARYNGEAL PAPILLOMATOSIS | 1999 |
|
RU2147841C1 |
METHOD FOR CARRYING OUT INTERFERON THERAPY | 1995 |
|
RU2105566C1 |
METHOD FOR DETERMINING PRODUCTION OF INTERFERONS AS CONGENITAL IMMUNITY PARAMETERS | 2017 |
|
RU2657808C1 |
METHOD FOR TREATMENT OF UROGENITAL INFECTIONS THAT ARE SEXUALLY TRANSMITTED AND CAUSED BY CHLAMYDIAE AND/OR MICOPLASMA | 2010 |
|
RU2441584C1 |
CARBOXYMETHYLCELLULOSE COPOLYMER AND GOSSYPOL SODIUM SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR PROPHYLAXIS OR TREATMENT OF VIRAL DISEASE | 2004 |
|
RU2270708C1 |
ANALGETIC AND ANTI-ITCHING AGENT | 1997 |
|
RU2147440C1 |
METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
Authors
Dates
2002-04-27—Published
2000-12-05—Filed